Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CLAV | 250MG 125MG | TABLET | Resolved | 2020-01-15 | 2020-02-19 | 103357 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2023-02-16 | 2023-03-16 | 185039 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185483 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2023-09-22 | 2023-12-08 | 204990 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2023-09-28 | 2023-10-06 | 205483 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-01-26 | 2024-03-01 | 217490 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-03-22 | 2024-04-05 | 223046 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223052 |
| APO-AMOXI CLAV | 400MG 57MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2019-05-18 | 41 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-02-11 | 2022-02-18 | 154749 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2022-10-28 | 2022-11-11 | 172960 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-12-05 | 2023-01-06 | 177132 |
| APO-AMOXI CLAV | 125MG 500MG | TABLET | Resolved | 2025-02-20 | 2025-02-28 | 250941 |
| APO-AMOXI CLAV | 125MG 500MG | TABLET | Actual shortage | 2025-03-20 | 2025-03-20 | 253070 |
| APO-AMOXI CLAV | 875MG 125MG | TABLET | Resolved | 2019-06-19 | 2019-09-23 | 87057 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2018-09-09 | 44 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2019-05-13 | 49 |
| APO-AMOXI CLAV 875/125 | 875MG 125MG | TABLET | Resolved | 2017-03-11 | 2017-04-25 | 636 |
| APO-AMOXI CLAV 875/125 | 875MG 125MG | TABLET | Resolved | 2017-06-05 | 2017-09-05 | 11959 |
| APO-AMOXI CLAV 875/125 | 875MG 125MG | TABLET | Resolved | 2018-02-05 | 2018-04-18 | 38473 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |